Asahi Kasei Inaugurates New Bioprocess Technical Center

Business Strategy Asahi Kasei Inaugurates New Bioprocess Technical Center

2024-01-03 Source: Press release Asahi Kasei 1 min Reading Time

Related Vendors

ASAHI KASEI EUROPE GmbH

Italvacuum, Srl

TRM Filter d.o.o.

Angst+Pfister AG

Asahi Kasei and Asahi Kasei Medical have recently launched its new Bioprocess Technical Center in Jiangsu, China. With the establishment of this center, the two companies aim to cater to customers in the Chinese pharmaceutical industry.

Asahi Kasei and Asahi Kasei Medical have announced the opening of the Asahi Kasei (China) Bioprocess Technical Center (CBTC) in Suzhou, Jiangsu, China.(Source: Asahi Kasei) — Asahi Kasei and Asahi Kasei Medical have announced the opening of the Asahi Kasei (China) Bioprocess Technical Center (CBTC) in Suzhou, Jiangsu, China.
(Source: Asahi Kasei)

Tokyo/Japan – Asahi Kasei and Asahi Kasei Medical have announced the opening of the Asahi Kasei (China) Bioprocess Technical Center (CBTC) in Suzhou, Jiangsu, China, on November 23, 2023.

The bioprocess business of Asahi Kasei Medical, comprising bioprocess-related products used in the manufacture of biotherapeutics, biosafety testing services, and biopharmaceutical CDMO business, is one of the Asahi Kasei Group's "10 Growth Gears" (GG10) businesses to drive future growth.

As an affiliate of Asahi Kasei Medical, Asahi Kasei Bioprocess (Shanghai) Co. (AKBC) performs the import and sale of Planova virus removal filters, Biooptimal microfilters, and related equipment, to pharmaceutical companies in China. As an affiliate of Asahi Kasei, Asahi Kasei Microza (Hangzhou) Co. (AKMH) performs marketing in China for Microza modules based on hollow-fiber filtration, which is a core technology of the Asahi Kasei Group.

Asahi Kasei and Asahi Kasei Medical established CBTC in order to provide greater value to customers in the Chinese pharmaceutical industry by performing practical tests and technical support with both bioprocess products and Microza products, combining the strengths of the two businesses to meet customer needs.

The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics, while further leveraging Asahi Kasei's high-level technology for ultrafiltration and microfiltration.

(ID:49857496)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Business E-mail

Please enter a valid mailadress.

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Date: 08.12.2025

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.